Search
Patexia Research
Case number 1:18-cv-00914

Huvepharma EOOD et al v. E.I. Du Pont DE Nemours and Company et al > Documents

Date Field Doc. No.Description (Pages)
Sep 9, 2022 100 Patent/Trademark Report to Commissioner (Main Document) (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,026,150; 7,312,063; 8,455,232. (Attachments: # (1) Order)(nms)
Sep 9, 2022 100 Patent/Trademark Report to Commissioner (Order) (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,026,150; 7,312,063; 8,455,232. (Attachments: # (1) Order)(nms)
Sep 8, 2022 98 Stipulation of Dismissal (2)
Docket Text: JOINT Stipulation of Dismissal, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Auerbach, Brian) Modified on 9/8/2022 (nms).
Sep 8, 2022 99 Order (2)
Docket Text: SO ORDERED Granting [98] Joint Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/8/2022. (nms)
Aug 5, 2022 97 Status Report (2)
Docket Text: Joint Status Report, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Auerbach, Brian) Modified on 8/9/2022 (nms).
Aug 2, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: A joint status letter is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 8/2/2022. (nms)
Jun 21, 2022 95 Status Report (2)
Docket Text: Joint Status Report, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Auerbach, Brian) Modified on 6/21/2022 (nms).
Nov 8, 2020 17 Motion for Leave to Appear Pro Hac Vice (2)
Nov 8, 2020 17 Affidavit Certification of Alan White (1)
Nov 8, 2020 18 Motion for Leave to Appear Pro Hac Vice (2)
Nov 8, 2020 18 Affidavit Certification of Marc S. Segal (1)
Nov 8, 2020 19 Motion for Leave to Appear Pro Hac Vice (2)
Nov 8, 2020 19 Affidavit Certification of Robert R. Baron, Jr. (1)
Nov 8, 2020 20 Motion for Leave to Appear Pro Hac Vice (2)
Nov 8, 2020 20 Certification (1)
Nov 8, 2020 20 Certification (1)
Nov 8, 2020 20 Certification (1)
Nov 8, 2020 52 Motion for Leave to Appear Pro Hac Vice (2)
Nov 8, 2020 52 Certification by Counsel To Be Admitted Pro Hac Vice (1)
Nov 8, 2020 52 Certification by Counsel To Be Admitted Pro Hac Vice (1)
Nov 8, 2020 52 Certification by Counsel To Be Admitted Pro Hac Vice (1)
Nov 8, 2020 52 Certification by Counsel To Be Admitted Pro Hac Vice (1)
Nov 8, 2020 64 Motion for Leave to Appear Pro Hac Vice (1)
Nov 8, 2020 64 Certification of Yi Han (1)
Nov 8, 2020 69 Motion for Leave to Appear Pro Hac Vice (1)
Nov 8, 2020 69 Certification of Ryan E. Dowell (1)
Nov 8, 2020 81 Motion to Stay (3)
Nov 8, 2020 81 Text of Proposed Order (2)
Nov 8, 2020 82 Motion to Expedite (3)
Nov 8, 2020 82 Text of Proposed Order (1)
Aug 13, 2020 94 Status Report (3)
Docket Text: Joint Status Report, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Giusini, Brittany) Modified on 8/13/2020 (nms).
Jul 29, 2020 93 Notice Requesting Removal of Co-Counsel (2)
Docket Text: NOTICE requesting Clerk to remove Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, Yi Han, Carolyn M. Pirraglia, Ryan E. Dowell as co-counsel. Reason for request: Conflict of Interest. (Brauerman, Stephen)
May 9, 2020 92 Transcript (13)
Docket Text: Official Transcript of Oral Argument held on 8/21/19 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 6/1/2020. Redacted Transcript Deadline set for 6/9/2020. Release of Transcript Restriction set for 8/7/2020. (Triozzi, Heather)
Sep 5, 2019 91 Redacted Document (9)
Docket Text: REDACTED VERSION of [88] Exhibit H, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Giusini, Brittany) Modified on 9/6/2019 (nms).
Sep 4, 2019 N/A Redaction Notice (0)
Docket Text: SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[88]. (nms)
Aug 30, 2019 N/A Redaction Notice (0)
Aug 21, 2019 N/A Oral Argument (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Oral Argument held on 8/21/2019. Local counsel present for plaintiffs: S. Brauerman. Local counsel present for defendants: B. Moskow-Schnoll. (Court Reporter Heather Triozzi.) (crb)
Aug 21, 2019 90 Order Administratively Closing Case (1)
Docket Text: ORDER Administratively Closing Case (see Order for further details). Signed by Judge Richard G. Andrews on 8/21/2019. (nms)
Aug 19, 2019 87 Reply Brief (10)
Aug 19, 2019 87 Exhibits (31)
Aug 19, 2019 87 Reply Brief (Main Document) (10)
Docket Text: REPLY BRIEF re [81] MOTION to Stay Pending Inter Partes Review, filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Exhibits I-J)(Moskow-Schnoll, Beth) Modified on 8/20/2019 (nms).
Aug 19, 2019 87 Reply Brief (Exhibits) (30)
Docket Text: REPLY BRIEF re [81] MOTION to Stay Pending Inter Partes Review, filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Exhibits I-J)(Moskow-Schnoll, Beth) Modified on 8/20/2019 (nms).
Aug 16, 2019 86 Redacted Document (30)
Docket Text: REDACTED VERSION of [85] Response to Motion, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 8/20/2019 (nms).
Aug 14, 2019 N/A Oral Order (0)
Aug 13, 2019 83 Opening Brief in Support (19)
Aug 13, 2019 83 Exhibits A to G (281)
Aug 13, 2019 81 Motion to Stay (Main Document) (3)
Docket Text: MOTION to Stay Pending Inter Partes Review - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Proposed Order)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Aug 13, 2019 81 Motion to Stay (Text of Proposed Order) (2)
Docket Text: MOTION to Stay Pending Inter Partes Review - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Proposed Order)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Aug 13, 2019 82 Motion to Expedite (Main Document) (3)
Docket Text: MOTION to Expedite Briefing on Motion to Stay Pending Inter Partes Review - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Proposed Order)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Aug 13, 2019 82 Motion to Expedite (Text of Proposed Order) (1)
Docket Text: MOTION to Expedite Briefing on Motion to Stay Pending Inter Partes Review - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Proposed Order)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Aug 13, 2019 83 Opening Brief in Support (Main Document) (19)
Docket Text: OPENING BRIEF in Support re [81] MOTION to Stay Pending Inter Partes Review, filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.Answering Brief/Response due date per Local Rules is 8/27/2019. (Attachments: # (1) Exhibits A-G)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Aug 13, 2019 83 Opening Brief in Support (Exhibits A to G) (30)
Docket Text: OPENING BRIEF in Support re [81] MOTION to Stay Pending Inter Partes Review, filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.Answering Brief/Response due date per Local Rules is 8/27/2019. (Attachments: # (1) Exhibits A-G)(Moskow-Schnoll, Beth) Modified on 8/14/2019 (nms).
Jul 29, 2019 80 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Defendants Objections and Responses to Plaintiffs Second Set of Interrogatories (NOS. 6- 13); and (2) Defendants Objections and Responses to Plaintiffs Third Set of Document Requests (NOS. 54-55) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Jul 24, 2019 79 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Defendants Second Set of Interrogatories; and (2) Defendants Second Set of Requests for the Production of Documents and Things filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Jul 12, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [78] STIPULATION TO EXTEND TIME for substantial completion of document production to August 30, 2019. Signed by Judge Richard G. Andrews on 7/12/2019. (nms)
Jul 11, 2019 78 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for substantial completion of document production to August 30, 2019 - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Giusini, Brittany)
Jun 28, 2019 76 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for Production (Nos. 54-55) and Plaintiffs' Second Set of Interrogatories (Nos. 6-13) filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Jun 26, 2019 74 Proposed Order (2)
Docket Text: PROPOSED Claim Construction Order, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 6/26/2019 (nms).
Jun 26, 2019 75 Order (2)
Docket Text: CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 6/26/2019. (nms)
Jun 21, 2019 73 Memorandum Opinion (17)
Docket Text: MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent Nos. 6,451,572, 7,026,150, 7,312,063, 7,829,318, 8,455,232, and 8,993,300. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion suitable for submission to the jury. Signed by Judge Richard G. Andrews on 6/21/2019. Associated Cases: 1:18-cv-00129-RGA, 1:18-cv-00914-RGA(nms)
Jun 7, 2019 N/A Redaction Notice (0)
Jun 7, 2019 70 Redacted Document (30)
Docket Text: REDACTED VERSION of [65] Joint Claim Construction Brief, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 6/7/2019 (nms).
Jun 7, 2019 71 Redacted Document (30)
Docket Text: REDACTED VERSION of [66] Appendix, Volume 1, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 6/7/2019 (nms).
Jun 7, 2019 72 Redacted Document (30)
Docket Text: REDACTED VERSION of [67] Appendix, Volume 2, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 6/7/2019 (nms).
Jun 6, 2019 N/A Redaction Notice (0)
Jun 6, 2019 N/A Markman Hearing (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 6/6/2019. Counsel present for plaintiffs: R. Maier, A. Vaidya. Local counsel present for defendants: D. Bilson, B. Moskow-Schnoll. (Court Reporter Jennifer Guy.) Associated Cases: 1:18-cv-00129-RGA, 1:18-cv-00914-RGA(crb)
Jun 4, 2019 N/A SO ORDERED (0)
Jun 4, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Ryan E. Dowell for Huvepharma EOOD, for Huvepharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 3, 2019 69 Motion for Leave to Appear Pro Hac Vice (Main Document) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan E. Dowell - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification of Ryan E. Dowell)(Bussiere, Sara)
Jun 3, 2019 69 Motion for Leave to Appear Pro Hac Vice (Certification of Ryan E. Dowell) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan E. Dowell - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification of Ryan E. Dowell)(Bussiere, Sara)
May 28, 2019 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The appendices filed at D.I. 66, D.I. 67, and D.I. 68 have been removed from the docket. The appendix is to be refiled in a more efficient format (2 volumes). Each volume also needs to include a captioned cover page identifying with its title the volume number and exhibits/tabs included therein. (nms)
May 28, 2019 68 Claim Construction Chart (4)
Docket Text: Joint Chart of Claim Terms and Constructions, by Huvepharma EOOD, Huvepharma, Inc.. (Tigan, Jeremy) Modified on 5/28/2019 (nms).
May 22, 2019 N/A SO ORDERED (0)
May 22, 2019 N/A Add Attorneys Pro Hac Vice (0)
May 21, 2019 64 Motion for Leave to Appear Pro Hac Vice (Main Document) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Yi Han - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification of Yi Han)(Brauerman, Stephen)
May 21, 2019 64 Motion for Leave to Appear Pro Hac Vice (Certification of Yi Han) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Yi Han - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification of Yi Han)(Brauerman, Stephen)
May 16, 2019 63 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
May 6, 2019 62 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Claim Construction Reply Brief and (2) this Notice of Service filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
May 2, 2019 61 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Defendants Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-5); and (2) Defendants Objections and Responses to Plaintiffs Second Set of Document Requests (Nos. 48-53) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
May 1, 2019 N/A Oral Order (0)
Apr 25, 2019 59 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Dr. Fei Philip Gao on April 30, 2019 filed by Huvepharma EOOD, Huvepharma, Inc..(Bussiere, Sara)
Apr 22, 2019 58 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendants Answering Claim Construction Brief filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Apr 10, 2019 57 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Objections to Defendants' Notice of Deposition Pursuant to Rule 30(b)(1) to Michael Benedik; and (2) Notice of Service filed by Huvepharma EOOD, Huvepharma, Inc..(Bussiere, Sara)
Apr 8, 2019 56 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants/Counterclaim Plaintiffs Notice to Depose Dr. Michael Benedik filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Apr 2, 2019 55 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Nos. 1-5) and Plaintiffs' Second Set of Requests for Production (Nos. 48-53) filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Mar 22, 2019 54 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Opening Construction Brief filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Mar 20, 2019 N/A Add Attorneys Pro Hac Vice (0)
Mar 20, 2019 N/A Add Attorneys Pro Hac Vice (0)
Mar 19, 2019 N/A Add Attorneys Pro Hac Vice (0)
Mar 12, 2019 N/A SO ORDERED (0)
Mar 12, 2019 53 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Brian S.S. Auerbach on behalf of Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company (Auerbach, Brian)
Mar 12, 2019 52 Motion for Leave to Appear Pro Hac Vice (Main Document) (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, and Carolyn M. Pirraglia - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification, # (4) Certification)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 12, 2019 52 Motion for Leave to Appear Pro Hac Vice (Certification by Counsel To Be Admitted Pro Hac Vice) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, and Carolyn M. Pirraglia - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification, # (4) Certification)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 12, 2019 52 Motion for Leave to Appear Pro Hac Vice (Certification by Counsel To Be Admitted Pro Hac Vice) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, and Carolyn M. Pirraglia - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification, # (4) Certification)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 12, 2019 52 Motion for Leave to Appear Pro Hac Vice (Certification by Counsel To Be Admitted Pro Hac Vice) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, and Carolyn M. Pirraglia - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification, # (4) Certification)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 12, 2019 52 Motion for Leave to Appear Pro Hac Vice (Certification by Counsel To Be Admitted Pro Hac Vice) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert L. Maier, Jennifer C. Tempesta, Michael E. Knierim, and Carolyn M. Pirraglia - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification, # (4) Certification)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (19)
Mar 8, 2019 51 Exhibit 1 (44)
Mar 8, 2019 51 Exhibit 2 (46)
Mar 8, 2019 51 Exhibit 3 (46)
Mar 8, 2019 51 Exhibit 4 (46)
Mar 8, 2019 51 Exhibit 5 (46)
Mar 8, 2019 51 Exhibit 6 (47)
Mar 8, 2019 51 Exhibit 7 (101)
Mar 8, 2019 51 Exhibit 8 (131)
Mar 8, 2019 51 Exhibit 9 (106)
Mar 8, 2019 51 Exhibit 10 (36)
Mar 8, 2019 51 Exhibit 11 (67)
Mar 8, 2019 51 Exhibit 12 (36)
Mar 8, 2019 51 Exhibit 13 (5)
Mar 8, 2019 51 Exhibit 14 (4)
Mar 8, 2019 51 Exhibit 15 (8)
Mar 8, 2019 51 Claim Construction Chart (Main Document) (19)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 1) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 2) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 3) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 4) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 5) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 6) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 7) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 8) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 9) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 10) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 11) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 12) (30)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 13) (5)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 14) (4)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Mar 8, 2019 51 Claim Construction Chart (Exhibit 15) (8)
Docket Text: Joint Claim Construction Statement, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15)(Brauerman, Stephen) Modified on 3/12/2019 (nms).
Feb 25, 2019 50 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiff's List of Proposed Claim Terms for Construction filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Feb 22, 2019 47 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiff Huvepharma Eood and Huvepharma, Inc's Objections and Responses to Defendants' First Set of Interrogatories and Objections and Responses to Defendants' First Set of Requests for Production of Documents filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Feb 22, 2019 48 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants List of Proposed Claim Terms for Construction filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Feb 22, 2019 49 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs' First Set of Document Requests (Nos. 1-47) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Feb 11, 2019 45 Order Setting Mediation Conferences (2)
Docket Text: ORDER Setting Mediation Conferences: Continuation of mediation is tentatively scheduled for 5/10/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/11/19. (cak)
Feb 11, 2019 46 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Disclosures Pursuant to Paragraph 4(d) of the Delaware Default Standards for Discovery filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Jan 16, 2019 44 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories (Nos. 1-7) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Jan 11, 2019 43 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to District of Delaware Default Standard for Discovery Paragraph 4(C) filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Jan 8, 2019 42 Order Setting Mediation Conferences (7)
Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 2/8/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 1/8/19. (cak)
Jan 4, 2019 40 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Document Requests (Nos. 1-47) filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Jan 4, 2019 41 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for the Production of Documents and Things (Nos. 1-49) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Dec 12, 2018 39 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Dec 7, 2018 37 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Dec 7, 2018 38 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Dec 4, 2018 36 Order (18)
Docket Text: SO ORDERED Granting [35] Stipulated Protective Order. Signed by Judge Richard G. Andrews on 11/30/2018. (nms)
Nov 30, 2018 35 Proposed Order (18)
Docket Text: PROPOSED Stipulated Protective Order, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 11/30/2018 (nms).
Nov 29, 2018 34 Answer to Counterclaim (4)
Docket Text: ANSWER to [29] Answer to Amended Complaint, and Counterclaim, by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen) Modified on 11/30/2018 (nms).
Nov 28, 2018 N/A Oral Order (0)
Nov 19, 2018 N/A SO ORDERED (0)
Nov 16, 2018 32 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to File the Protective Order to November 30, 2018 - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Giusini, Brittany) Modified on 11/16/2018 (nms).
Nov 12, 2018 31 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to District of Delaware Default Standard for Discovery Paragraph 4(a) filed by Huvepharma EOOD, Huvepharma, Inc..(Bussiere, Sara)
Nov 9, 2018 28 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Plaintiff Huvepharma Eood and Huvepharma, Inc's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Huvepharma EOOD, Huvepharma, Inc..(Brauerman, Stephen)
Nov 9, 2018 29 Answer to Amended Complaint (30)
Docket Text: ANSWER to [23] Amended Complaint, and COUNTERCLAIMS against All Plaintiffs by DuPont Industrial Biosciences USA, LLC, Danisco USA, Inc., Danisco US Inc., E.I. Du Pont DE Nemours and Company.(Giusini, Brittany) Modified on 11/9/2018 (nms).
Nov 9, 2018 30 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company.(Giusini, Brittany)
Nov 2, 2018 N/A SO ORDERED (0)
Nov 1, 2018 27 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to File the Protective Order to November 16, 2018 - filed by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen)
Oct 15, 2018 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
Oct 15, 2018 26 Scheduling Order (9)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/22/2019. Amended Pleadings due by 2/22/2019. Discovery due by 12/13/2019. Dispositive Motions due by 8/7/2020. Answering Brief due 9/11/2020. Reply Brief due 9/25/2020. Joint Claim Construction Brief due by 5/24/2019. A Markman Hearing is set for 6/6/2019, at 9:30 AM in Courtroom 6A. A Pretrial Conference is set for 1/29/2021, at 9:00 AM in Courtroom 6A. A 5 day Jury Trial is set to start 2/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/12/2018. (nms)
Oct 12, 2018 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 10/12/2018. Counsel to submit a revised Order with agreed upon dates. (Court Reporter Taneha Carroll - Hawkins Reporting Service.) (ksr, )
Oct 12, 2018 25 Proposed Order (9)
Docket Text: PROPOSED Scheduling Order, by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen) Modified on 10/12/2018 (nms).
Oct 10, 2018 N/A SO ORDERED (0)
Oct 10, 2018 23 Amended Complaint (30)
Docket Text: AMENDED COMPLAINT against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company- filed by Huvepharma EOOD, Huvepharma, Inc..(nms)
Oct 10, 2018 24 Proposed Order (9)
Docket Text: PROPOSED Scheduling Order, by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Moskow-Schnoll, Beth) Modified on 10/11/2018 (nms).
Oct 9, 2018 22 Stipulation (2)
Oct 9, 2018 22 Exhibit A (476)
Oct 9, 2018 22 Exhibit B (50)
Oct 9, 2018 22 Stipulation (Main Document) (2)
Docket Text: STIPULATION to File Amended Complaint and Extend Deadline to Respond to Amended Complaint, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Brauerman, Stephen) Modified on 10/10/2018 (nms).
Oct 9, 2018 22 Stipulation (Exhibit A) (30)
Docket Text: STIPULATION to File Amended Complaint and Extend Deadline to Respond to Amended Complaint, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Brauerman, Stephen) Modified on 10/10/2018 (nms).
Oct 9, 2018 22 Stipulation (Exhibit B) (30)
Docket Text: STIPULATION to File Amended Complaint and Extend Deadline to Respond to Amended Complaint, by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Brauerman, Stephen) Modified on 10/10/2018 (nms).
Oct 4, 2018 N/A SO ORDERED (0)
Oct 4, 2018 21 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Huvepharma EOOD, Huvepharma, Inc.. (Brauerman, Stephen)
Oct 4, 2018 20 Motion for Leave to Appear Pro Hac Vice (Main Document) (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard E. Parke, Ken Sheets, Ajit Vaidya - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification)(Brauerman, Stephen) Modified on 10/4/2018 (nms).
Oct 4, 2018 20 Motion for Leave to Appear Pro Hac Vice (Certification) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard E. Parke, Ken Sheets, Ajit Vaidya - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification)(Brauerman, Stephen) Modified on 10/4/2018 (nms).
Oct 4, 2018 20 Motion for Leave to Appear Pro Hac Vice (Certification) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard E. Parke, Ken Sheets, Ajit Vaidya - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification)(Brauerman, Stephen) Modified on 10/4/2018 (nms).
Oct 4, 2018 20 Motion for Leave to Appear Pro Hac Vice (Certification) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard E. Parke, Ken Sheets, Ajit Vaidya - filed by Huvepharma EOOD, Huvepharma, Inc.. (Attachments: # (1) Certification, # (2) Certification, # (3) Certification)(Brauerman, Stephen) Modified on 10/4/2018 (nms).
Sep 26, 2018 N/A Add Attorneys Pro Hac Vice (0)
Sep 25, 2018 N/A Add Attorneys Pro Hac Vice (0)
Sep 24, 2018 N/A SO ORDERED (0)
Sep 24, 2018 N/A Add Attorneys Pro Hac Vice (0)
Sep 24, 2018 16 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Brittany M. Giusini on behalf of Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company (Giusini, Brittany)
Sep 24, 2018 17 Motion for Leave to Appear Pro Hac Vice (Main Document) (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alan White - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 24, 2018 17 Motion for Leave to Appear Pro Hac Vice (Affidavit Certification of Alan White) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alan White - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 24, 2018 18 Motion for Leave to Appear Pro Hac Vice (Main Document) (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc S. Segal - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 24, 2018 18 Motion for Leave to Appear Pro Hac Vice (Affidavit Certification of Marc S. Segal) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc S. Segal - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 24, 2018 19 Motion for Leave to Appear Pro Hac Vice (Main Document) (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert R. Baron, Jr. - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 24, 2018 19 Motion for Leave to Appear Pro Hac Vice (Affidavit Certification of Robert R. Baron, Jr.) (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert R. Baron, Jr. - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Attachments: # (1) Certification)(Moskow-Schnoll, Beth) Modified on 9/24/2018 (nms).
Sep 21, 2018 11 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent DowDuPont Inc. for E.I. Du Pont DE Nemours and Company filed by E.I. Du Pont DE Nemours and Company. (Moskow-Schnoll, Beth)
Sep 21, 2018 12 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent DowDuPont Inc. for DuPont Industrial Biosciences USA, LLC filed by DuPont Industrial Biosciences USA, LLC. (Moskow-Schnoll, Beth)
Sep 21, 2018 13 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent E.I. Du Pont deNemours and Company, Corporate Parent DowDuPont Inc., Corporate Parent Specialty Products N&H, Inc. for Danisco USA, Inc. filed by Danisco USA, Inc.. (Moskow-Schnoll, Beth)
Sep 21, 2018 14 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent E.I. DuPont de Nemours and Company, Corporate Parent DowDuPont Inc., Corporate Parent Danisco Holding USA Inc. for Danisco US Inc. filed by Danisco US Inc.. (Moskow-Schnoll, Beth)
Sep 21, 2018 15 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 10/12/2018, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/21/2018. (nms)
Sep 19, 2018 N/A CORRECTING ENTRY: (0)
Sep 18, 2018 10 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Huvepharma EOOD, Huvepharma, Inc., by E.I. Du Pont DE Nemours and Company, DuPont Industrial Biosciences USA, LLC, Danisco USA, Inc., and Danisco US, Inc..(Moskow-Schnoll, Beth) Modified on 9/19/2018 (nms). Modified on 9/19/2018 (nms).
Aug 24, 2018 N/A SO ORDERED (0)
Aug 23, 2018 9 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the complaint to September 18, 2018 - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Moskow-Schnoll, Beth) Modified on 8/24/2018 (nms).
Jul 18, 2018 N/A SO ORDERED (0)
Jul 18, 2018 8 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the complaint to August 28, 2018 - filed by Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (Moskow-Schnoll, Beth)
Jun 29, 2018 4 Summons Returned Executed (2)
Docket Text: Alias SUMMONS Returned Executed by Huvepharma, Inc., Huvepharma EOOD. Danisco US Inc. served on 6/28/2018, answer due 7/19/2018. (Brauerman, Stephen)
Jun 29, 2018 5 Summons Returned Executed (2)
Docket Text: Alias SUMMONS Returned Executed by Huvepharma, Inc., Huvepharma EOOD. Danisco USA, Inc. served on 6/28/2018, answer due 7/19/2018. (Brauerman, Stephen)
Jun 29, 2018 6 Summons Returned Executed (2)
Docket Text: Alias SUMMONS Returned Executed by Huvepharma, Inc., Huvepharma EOOD. DuPont Industrial Biosciences USA, LLC served on 6/28/2018, answer due 7/19/2018. (Brauerman, Stephen)
Jun 29, 2018 7 Summons Returned Executed (2)
Docket Text: Alias SUMMONS Returned Executed by Huvepharma, Inc., Huvepharma EOOD. E.I. Du Pont DE Nemours and Company served on 6/28/2018, answer due 7/19/2018. (Brauerman, Stephen)
Jun 28, 2018 N/A Summons Reissued (0)
Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company. (nmg)
Jun 27, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Jun 20, 2018 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Danisco US Inc. on 6/20/2018; Danisco USA, Inc. on 6/20/2018; DuPont Industrial Biosciences USA, LLC on 6/20/2018; E.I. Du Pont DE Nemours and Company on 6/20/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar)
Jun 20, 2018 1 Complaint (29)
Jun 20, 2018 1 Exhibit 1 (46)
Jun 20, 2018 1 Exhibit 2 (46)
Jun 20, 2018 1 Exhibit 3 (46)
Jun 20, 2018 1 Exhibit 4 (30)
Jun 20, 2018 1 Exhibit 5 (15)
Jun 20, 2018 1 Exhibit 6 (10)
Jun 20, 2018 1 Exhibit 7 (5)
Jun 20, 2018 1 Exhibit 8 (2)
Jun 20, 2018 1 Exhibit 9 (15)
Jun 20, 2018 1 Exhibit 10 (15)
Jun 20, 2018 1 Exhibit 11 (21)
Jun 20, 2018 1 Exhibit 12 (10)
Jun 20, 2018 1 Exhibit 13 (11)
Jun 20, 2018 1 Exhibit 14 (8)
Jun 20, 2018 1 Exhibit 15 (5)
Jun 20, 2018 1 Exhibit 16 (5)
Jun 20, 2018 1 Exhibit 17 (3)
Jun 20, 2018 1 Exhibit 18 (12)
Jun 20, 2018 1 Exhibit 19 (4)
Jun 20, 2018 1 Civil Cover Sheet (1)
Jun 20, 2018 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar)
Jun 20, 2018 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,026,150 ;7,312,063 ;8,455,232. (sar)
Jun 20, 2018 1 Complaint (Main Document) (29)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 1) (30)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 2) (30)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 3) (30)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 4) (30)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 5) (15)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 6) (10)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 7) (5)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 8) (2)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 9) (15)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 10) (15)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 11) (21)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 12) (10)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 13) (11)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 14) (8)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 15) (5)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 16) (5)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 17) (3)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 18) (12)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Exhibit 19) (4)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint (Civil Cover Sheet) (1)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Danisco US Inc., Danisco USA, Inc., DuPont Industrial Biosciences USA, LLC, E.I. Du Pont DE Nemours and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2405335.) - filed by Huvepharma, Inc., Huvepharma EOOD. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Civil Cover Sheet)(sar)
Jun 20, 2018 1 Complaint* (1)
Menu